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ABSTRACT
Objectives: As an ever growing scale people are using newer and more effective drugs for various medical conditions. Adverse drug reactions (ADRs) 
are preventable if the health-care professional pays close attention to the details of the adverse effects, following a drug administration. Awareness 
about ADRs can decrease the irrational use of drugs. Hence, there is an urgent need to create awareness among the prescribers about the ADR 
monitoring. Hence, this study is undertaken to assess the awareness, knowledge, and attitude toward Pharmacovigilance among the future health-
care professionals.
Methods: Questionnaire-based study was conducted in a tertiary health-care hospital after getting approval from the Institutional Ethical Committee. 
The questionnaire was developed to assess the knowledge, awareness, and practice of Pharmacovigilance activity. The questions were distributed to 
the final year students, interns, and postgraduate’s students and allowed to write down the answers independently. Each correct answer was given a 
score of ‘1,’ whereas the incorrect/incomplete was given a score of “0.”
Results and Conclusion: The study reported that awareness (UGs - 53.3%, interns - 54.9%, PGs - 30.75) was adequate among undergraduates 
and interns, in the knowledge part (UGs-65.5%, interns - 35.4%, PGs - 9.2%), undergraduates excel far than the interns and PGs. However, in the 
application of Pharmacovigilance (UG - 22.2%, interns - 59.8%, PGs - 63.1%) postgraduates and interns fair better than the undergraduates. Hence, 
there is need to increase the awareness and also increase the ADR reporting practice among medical graduates.
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INTRODUCTION
Drug disasters have played a key role in the awareness of adverse drug 
reaction (ADRs). The thalidomide disaster has served an important role 
in the improvement of drug regulation safety needs and triggered the 
spontaneous reporting of ADRs globally. There are 3 actions of a drug, 
the one you want, the one you do not want, and the one you do not know 
about [1]. Hence, it is crucial to monitor both the known and unknown 
adverse effects of medicines. This is often paraphrased by saying that 
all drugs are poisons, the dose alone making the difference. In various 
studies, ADRs have been implicated as a leading cause of considerable 
morbidity and mortality [2].
ADRs can arise from many sources even if a drug is correctly selected 
and dosed. To the patient, an unnecessary hospital admission caused 
by ADRs is a needless loss of health as well as an unnecessary loss of 
quality of life [3]. Thus, prevention of unnecessary hospitalization by 
ADRs is a key goal in health policy decision-making.
In a country like India, with a huge population and vast diversity, it 
is absolutely necessary to introduce a standard Pharmacovigilance 
programme in each medical college and hospitals across the country. 
Pharmacovigilance is by definition “the science and activities which are 
related to the detection, assessment, understanding, and the prevention 
of adverse effects or any other drug-related problems [4]. India ranks 
below 1% in terms of ADR reporting against the world rate of 5% [5]. 
To overcome this problem, the Ministry of Health and Family Welfare, 
Government of India, has initiated the National Pharmacovigilance 
programme. The purpose of this program is to gather the data, analyze 
it, and to use inferences to propose informing regulatory interventions, 
besides communicating the risks to the health-care professionals and the 
public. This program is coordinated by the National Pharmacovigilance 
Centre at the Central Drugs Standard Control Organization in New Delhi. 
The National Center is operating under the supervision of the National 
Pharmacovigilance Advisory Committee, to recommend procedures 
and guidelines for regulatory interventions. This committee oversees 
the performance of two zonal, five regional, and twenty-six peripheral 
Pharmacovigilance centers. The entire network works in coordination 
to improve the ADR reporting in our country [6].
India has become a destination for conducting clinical trials. 
During clinical trials, drugs are commonly studied in a safeguarded 
environment, for a relatively small number of patients, and usually for 
a limited duration. These trials at times exclude the elderly, the very 
young, and patients with comorbidities. Often patients on multiple drug 
therapy and patients with decreased renal and hepatic function are 
disqualified. For these patient populations, any susceptibility to ADRs 
may be missed. Adverse reactions may occur at such a low frequency 
that they are not being detected in the small numbers of patients 
included in clinical trials. Furthermore, it is very difficult to foretell 
how practitioners will really use medications in practice. Once the 
drug is commercially available, the exclusion criteria applied in clinical 
trials, no longer exist. Thus the use of drug in general population either 
short term or long term may increase the possibility of identifying 
unobserved adverse effects. In addition, widespread use of medicines in 
the general population can increase the chances for uncovering adverse 
reactions occurring at low frequency and thus not previously detected 
during the marketing approval process.
Pharmacovigilance is now accepted to be an uninterrupted practice 
of evaluation accompanied by steps to improve safe use of medicines 
which involve pharmaceutical companies, regulatory authorities, health 
professionals, and patients. Pharmacovigilance is particularly important 
since most of the adverse effects are reversible by modifying the dosage 
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or omitting the offending medicine. All medicines (pharmaceuticals 
and vaccines) have side effects. In a vast country like India with a 
population of over 1.2 Billion with vast cultural blend, different disease 
occurrence patterns, practice of different systems of medicines, 
different socioeconomic status, it is important to have a standardized 
and healthy Pharmacovigilance and drug safety monitoring program 
for the nation. Concern for ADRs in highly vulnerable populations is of 
even greater concern.
Pharmacovigilance programs have played a major role in detection of 
ADRs and banning of a number of drugs from the market. However, 
underreporting of ADRs is one of the major problems associated with 
Pharmacovigilance programs. Although Pharmacovigilance programs 
are victorious in improving drug use patterns, underreporting of ADRs 
is felt as a major problem. ADR may not be reversible or may escalate 
into severe consequences. In the long run, this ADR may spread out in 
different parts of the world with the same symptoms as no professional 
engaged in prescribing the doses takes pain in reporting the matter to 
the concerned agency. Such a casual approach may prove fatal to the 
large population and at times be cost-effective and result into loss of 
valuable workforce. At last medicine, despite promising ingredients to 
cure the disease, is discarded and the other alternatives are searched 
upon [7]. The Herculean task is to foster a culture of reporting among 
the clinicians, especially among the junior doctors, as they are more 
closely associated with the patient care. The present low level of ADR 
reporting is mostly due to a lack of awareness and training and time 
constraints [8]. The way in which a doctor takes the clinical record of a 
patient can be improved if he has a sound knowledge of the drug safety 
issues, with an importance on the patient’s medication history. It also 
helps him in understanding the action of the drug better. It thus decreases 
the irrational use of medicines, adverse drug-drug interactions, and 
inappropriate polypharmacy [9]. To expand the reporting rate, it is vital 
to improve the knowledge, attitude, and practices (KAP) of the health-
care professionals regarding ADR reporting and Pharmacovigilance. 
Before carrying out any intervention, it is necessary to evaluate the 
baseline KAP of the health-care professionals regarding ADR monitoring 
and Pharmacovigilance [10]. Pharmacovigilance plays an important 
role in the rational use of medicines by providing information about 
ADRs in the general population. Communicating the potential harm 
of drug use to patients is a matter of high priority and should be 
carried out by every prescriber [11]. One of the important long-term 
goals of this program is to develop a reporting culture among health-
care professionals and make ADR reporting mandatory for health-
care professionals [12,13]. Studies from different settings indicate 
inadequate knowledge about Pharmacovigilance among health-care 
professionals as well as attitudes that are associated with a high degree 
of underreporting [13] detection, recording, and reporting of ADRs is of 




This was a noninterventional study which was done among the final 
year MBBS students, interns, and the postgraduates who were studying 
at Sree Balaji Medical College, Chennai, after getting consent from them. 
Those who did not return the questionnaires in the stipulated time 
were excluded from the study. The study was conducted after getting 
approval from the Institutional Ethical Committee.
Fig. 1: Pharmacovigilance score of undergraduates
Fig. 2: Pharmacovigilance score of interns
Fig. 3: Pharmacovigilance score of postgraduates
Table 1: Awareness of pharmacovigilance among respondents
Grading Final year 
students (%)
Interns (%) Postgraduates (%)
Poor (below 25%) 11.1 (10/90) 18.3 (15/82) 18.4 (12/65)
Average (25-50%) 24.4 (22/90) 31.7 (26/82) 49.2 (32/65)
Good (51-75%) 53.3 (48/90) 54.9 (45/82) 30.75 (20/65)
Excellent  
(above 75%)
3.3 (3/90) 2.4 (2/82) 1.5 (1/65)
Table 2: Knowledge of pharmacovigilance among respondents
Grading Final year 
students
Interns Postgraduates
Poor (below 25%) 6.6 (6/90) 10.9 (9/82) 24.6 (16/65)
Average (25-50%) 28.8 (26/90) 43.9 (36/82) 64.6 (42/65)
Good (51-75%) 65.5 (59/90) 35.4 (29/82) 9.2 (6/65)
Excellent  
(above 75%)
6.7 (6/90) 2.4 (2/82) 1.5 (1/65)
Table 3: Application of pharmacovigilance among respondents
Grading (%) Final year 
students (%)
Interns (%) Postgraduates (%)
Poor (below 25) 24.4 (22/90) 9.75 (8/82) 3.1 (2/65)
Average (25-50) 52.2 (47/90) 28.1 (23/82) 27.7 (18/65)
Good (51-75) 22.2 (20/90) 59.8 (49/82) 63.1 (41/65)
Excellent  
(above 75)
1.11 (1/90) 2.4 (2/82) 6.2 (4/65)
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The study instrument
The study instrument was a predesigned questionnaire which was 
prepared by following the preference which was set by related 
studies. It was validated. The study questionnaire was designed to 
assess the awareness, knowledge, and the methods of application of 
Pharmacovigilance among the study population. The questionnaire is 
comprised 30 questions (awareness - 6, knowledge - 10, and methods 
of application - 14).
The study conduct
The questionnaire was administered to 250 final year MBBS students, 
interns, and postgraduates (from all specialties) of Sree Balaji 
Medical College. The participants were personally briefed about the 
questionnaire and they were requested to return the duly filled in 
forms. The participants were given 45 minutes to answer the questions 
and they were not allowed to consult anyone during that time. They 
could maintain ambiguity with regard to their names, but they had to 
write their designations. The questionnaire was designed in such a way 
that each question had only one correct answer. The questionnaires 
were then evaluated. One point was given to each answered question 
(max total - 30 points). All the 3 groups were categorized as poor if 
the score is below 25%, as average if the score is 26-50%, as good if 
the score is 51-75%, and as excellent if the score is above 75%. The 
questionnaires were then analyzed by grading the respondents into 
data from the completed questionnaires are charted categorically in 
MS  Excel sheet, analyzed and the results are expressed using suitable 
pictorial representations and percentages.
RESULTS
The questionnaire was administered to 250 participants, of whom 
70 were postgraduates from various departments, 90 were interns, 
and 90 were final year MBBS students. A total of 237 questionnaires 
were returned. (65 - postgraduates, 82 - interns, 90 - final year M.B.B.S 
students). Data from the completed questionnaires are charted 
categorically in MS Excel sheet, analyzed and the results are expressed 
using suitable pictorial representations and percentages. All the 
3 groups were categorized as poor if the score is below 25%, if the score 
is 26-50% as average, if the score is 51-75% as good, and if the score is 
above 75% as excellent. The questionnaire was analyzed by giving 1 for 
the correct response and 0 for the incorrect one. From this study, the 
following results were obtained.
Final year students (53.3%) and interns (54.9%) (Table 1) are better in 
the awareness of Pharmacovigilance than the postgraduates (30.75%). 
This is because they were educated about detection, assessment, 
understanding, and prevention of ADR to a certain extent in their 
syllabus.
In the knowledge regarding the existence of various programs, regional 
center, the yellow card system, schedule Y, when to report the adverse 
event in a clinical trial, etc., the undergraduates performed better than 
the interns and postgraduates (Table 2).
In the application of methods, the scores were considerably higher 
among the postgraduates (63.1%) and the interns (59.8%) as compared 
to the final year students (22.2%) (Table 3). This is because they use 
their meagre Pharmacovigilance knowledge into application, by their 
clinical exposure, handling drugs, and managing ADRs in the hospital. 
Even though they report adverse reactions to the Pharmacovigilance 
cell, they are less aware of the National programs available [14].
Even though the interns have very good awareness about Pharmacovigilance 
(Fig. 3), their knowledge is less when compared to final year students. Even 
though the undergraduates had very good awareness and knowledge, they 
performed poorly in the methods of application. This is because they were 
educated (Figs. 1 and 2), but they lack the performance skill or hands 
on training. Fortunately, attitudes are potentially flexible variables and 
the level to which medical students are informed about the principles of 
Pharmacovigilance and their practice has a large impact on ADRs reporting.
The data analyzed highlighted that even though the postgraduates lack 
in the knowledge part of pharmacovigilance programme, since they are 
actively involved in reporting adverse effects to the pharmacovigilance 
cell they are far better in the application skill of the same.
DISCUSSION
The incidences of adverse events are alarmingly increasing, with the 
increase in the entry of new drugs. The problem is further exacerbated 
by the inadequate training that clinicians receive in the basic principle 
of applied pharmacology and therapeutics. The adverse drug events 
may be attributable to the drugs, diagnostic agents, biologicals, 
nutrients, fluids, electrolytes, pharmaceutical excipient, or even the 
common components of the drug delivery systems. Occasionally, 
more than one agent is involved in causing the ADRs regardless of 
the route and mode of drug administration [15]. Monitoring of ADRs 
should be an essential constituent of patient care. It is now a well-
established fact that health-care professionals play a vital role in ADR 
reporting [16]. The awareness of the occurrence of adverse effects for 
drugs should be created and taught even from the medical student 
period. This awareness can to some extent lead to rational use of 
drugs. Hence, this study is undertaken to assess the awareness among 
the undergraduate, interns, and postgraduate medical students, who 
are the future pillars of this medical field. The numerous mutual and 
fiscal consequences of ADRs develop a need to vigorously involve 
health-care professionals in the pharmacovigilance programme. 
The main aims of the pharmacovigilance programme are the early 
detection of adverse effects, interactions and reporting the same to 
the concerned authorities. It is much more vital for the recognition 
of the risk factors for the adverse reactions and dissemination of the 
information which is essential to get better in the prescription of drugs. 
Hence, the main requirement of Pharmacovigilance is the reporting 
of suspected ADRs [17]. An appropriate harmonization among the 
health-care professionals and medical institutions is the most vital 
for a roaring Pharmacovigilance programme. Many factors are related 
with the ADR underreporting among the health-care professionals. 
However, basically, to improve the reporting rate, it is essential to 
appropriately educate health-care professionals as regards ADR 
reporting/Pharmacovigilance. The most fitting time to do so is during 
the undergraduate and the postgraduate training of the doctors. This 
study endeavored is to assess the extent of the awareness, knowledge, 
and methods of application of Pharmacovigilance of the final year 
MBBS students, interns, and postgraduates of a tertiary care hospital. 
This is because students, interns, and post graduates can play a key task 
in interacting with patients in the clinical departments.
CONCLUSION
The present study revealed that the medical students are better in 
awareness and knowledge than the interns and postgraduates. However, 
the interns and postgraduates are more skilled in the application which 
they perform using their meagre knowledge. Therefore, it is a necessity 
of the hour to implement Pharmacovigilance as part of the medical 
curriculum and also chances of application of knowledge into practice. 
There is a need to conduct workshop and conferences regarding the 
Pharmacovigilance programme.
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